Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5642 Journals
4484 Congresses
10100+ Unique Records

Letters in Drug Design & Discovery


Title Abbreviation
Lett Drug Des Discov
ISSN
1570-1808
Electronic ISSN
1875-628X
Therapeutic Area
Readership
Chemists, Medicinal Chemists, Pharmacologists, Scientists
Scope
Letters in Drug Design & Discovery publishes letters, full-length/mini-reviews, research articles, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of the latest Internet technology for both the submission and review of manuscripts. The journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
Bentham Science Publishers Ltd.
To see more details about Letters in Drug Design & Discovery, Subscribe Now!
Impact Factor JCR Categories/Rank Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
 
– Kait G
Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
– Michael K.
Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
- Weill Cornell Medical Library